Digestive System Diseases

633 trials 301 recruiting

Filter these 633 trials by phase, country and sponsor.

Open in Search →

Botox injection into the upper esophageal sphincter in inability to belch: a study comparing botox with placebo. Recruiting

2024-512546-42-00 retrograde cricopharyngeus dysfunction 6 2024-09-02
Prospective study in patients with colon or rectum cancer with liver metastasis of the efficacy and toxicity of standard therapy (chemothera… Recruiting

2024-517204-11-00 microsatellite stable (MSS) colorectal cancer with live 4 2024-08-30
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
Naldemedine OIBD Recruiting

2023-507744-36-00 Opioid induced bowel dysfunction 4 2024-08-12
The CLEAN-DUCT / TRITICC-3 trial - Phase IIa, prospective, single arm, open label, non-randomized, multi-center pilot study of durvalumab (M… Recruiting

2023-509165-21-00 Extrahepatic cholangiocarcinoma (eCCA) 4 2024-08-08
Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype Recruiting

2023-509183-17-00 Colorectal cancer, liver metastases 3 2024-08-01
A Study to Evaluate Whether Healing all Bowel Wall Layers is a Superior Treatment Target in Patients with Active Crohn’s Disease (CD). Recruiting

2023-509096-16-00 Moderately to Severely Active Crohn’s Disease 6 2024-07-31
Ezabenlimab (BI 754091) and DCFm (docetaxel, cisplatin and 5-fluorouracil) followed by chemoradiotherapy for the treatment of stage III anal… Recruiting

2024-514083-31-00 squamous cell anal carcinoma 4 2024-07-26
FFCD 2006 – NEORAF : A MULTI-CENTRE, OPEN-LABEL, PILOT TRIAL EVALUATING THE COMBINATION ENCORAFENIB AND CETUXIMAB IN A NEOADJUVANT SETTING I… Recruiting

2024-514107-34-00 BRAF V600E-MUTATED LOCALISED COLON OR UPPER RECTUM CANC 4 2024-07-18
CARE : Impact of Regorafenib in combination with multimodal metronomic chemotherapy (cyclophosphamide, capecitabine, and low-dose aspirin) o… Recruiting

2023-509761-21-00 Metastatic colorectal cancer 5 2024-07-08
A Phase 2 Study to Evaluate MORF-057 in Adults with Moderately to Severely Active Crohn’s Disease Recruiting

2023-508158-24-00 Moderately to Severely Active Crohn’s Disease 4 2024-06-25
Intraoperative Sufentanil and chronic postsurgical pain in non-major scheduled abdominal surgery Recruiting

2023-510140-21-00 Chronic postsurgical pain in non-major scheduled abdomi 6 2024-06-24
Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left … Recruiting

2023-509551-14-00 Unresectable left sided RAS/B-RAF wild-type metastatic 5 2024-06-12
PRODIGE 87 FOXTROT II : Personalising and refining neo-adjuvant chemotherapy in locally advanced but resectable colon cancer in the elderly … Recruiting

2023-505214-23-00 colon carcinoma 5 2024-06-07
A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet Recruiting

2023-506150-21-00 Celiac Disease 4 2024-05-29
Comparison of Vedolizumab treatment to Adalimumab dose intensification in Crohn’s disease patients with loss of response or biomarker activi… Recruiting

2023-508154-25-00 Crohn's disease 6 2024-05-27
Pro-RAPID Recruiting

2023-507352-72-00 Crohn's Disease 6 2024-05-24
Tocilizumab for Painful Chronic Pancreatitis (TOPAC-trial) Recruiting

2023-510084-35-00 Chronic pancreatitis 4 2024-05-21
Neoadjuvant Chemotherapy for Obstructive Colon cancER first Treated by cOlostomy : A randomized phase III trial - COnCERTO (French 01-18) 20… Recruiting

2024-516456-17-00 patients admitted for an obstructive colon cancer 5 2024-05-07
Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled, superiority… Recruiting

2023-504143-14-00 Chronic pancreatitis 6 2024-05-02
Budesonide as a treatment for inflammation in stomach complaints. Recruiting

2024-517035-43-00 Functional Dyspepsia 6 2024-05-01
Precision Medicine in patients with unresectable CholAngiocarcinoma; RadioEmbolization and combined biological therapy (PM-CARE). Single arm… Recruiting

2024-516498-57-00 liver predominant intrahepatic cholangiocarcinoma 4 2024-04-30
A novel COMBinATorial therapy with albumin and enoxaparin in patients with decompensated cirrhosis at high-risk of poor outcome (COMBAT tria… Recruiting

2023-507073-18-00 Cirrhosis 4 2024-04-24
Examining the impact of propranolol on preoperative anxiety and on tumorigenic changes in patients with pancreatic ductal adenocarcinomas: a… Recruiting

2023-506553-37-00 Pancreatic ductal adenocarcinoma (PDAC) 4 2024-04-23